Use of a murine cell line for identification of human nitric oxide synthase inhibitors (Q40228889)

18 September 2017

Use of a murine cell line for identification of human nitric oxide synthase inhibitors (English)

1 reference

18 September 2017

Saule Naureckiene

1

1 reference

18 September 2017

Wade Edris

2

1 reference

18 September 2017

Seena K Ajit

3

1 reference

18 September 2017

Alan H Katz

4

1 reference

18 September 2017

Kodangattil Sreekumar

5

1 reference

18 September 2017

Kathryn E Rogers

6

1 reference

18 September 2017

Jeffrey D Kennedy

7

1 reference

18 September 2017

Philip G Jones

8

1 reference

18 September 2017

17 August 2006

1 reference

Journal of Pharmacological and Toxicological Methods

18 September 2017

1 reference

18 September 2017

55

1 reference

18 September 2017

303-313

1 reference

18 September 2017

3

1 reference

Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Nitric oxide synthases: structure, function and inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

A classical enhancer element responsive to both lipopolysaccharide and interferon-gamma augments induction of the iNOS gene in mouse macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Measurement of nitric oxide in biological models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

N-terminal domain swapping and metal ion binding in nitric oxide synthase dimerization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

The expression and regulation of inducible nitric oxide synthase gene differ in macrophages from chickens of different genetic background

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Inducible nitric oxide synthase of macrophages. Present knowledge and evidence for species-specific regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Nitric oxide synthases in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Inducible nitric oxide synthase in human diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Suppression of arthritis by an inhibitor of nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

PPA250 [3-(2,4-difluorophenyl)-6-[2-[4-(1H-imidazol-1-ylmethyl) phenoxy]ethoxy]-2-phenylpyridine], a novel orally effective inhibitor of the dimerization of inducible nitric-oxide synthase, exhibits an anti-inflammatory effect in animal models of ch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Vascular endothelial cells synthesize nitric oxide from L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Molecular mechanisms regulating iNOS expression in various cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Inducible nitric oxide synthase requires both the canonical calmodulin-binding domain and additional sequences in order to bind calmodulin and produce nitric oxide in the absence of free Ca2+

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Important role of membrane-associated CD14 in the induction of IFN-beta and subsequent nitric oxide production by murine macrophages in response to bacterial lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Antifungal imidazoles block assembly of inducible NO synthase into an active dimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Synthesis of nitrogen oxides from L-arginine by macrophage cytosol: requirement for inducible and constitutive components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Blocking NO synthesis: how, where and why?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Ganoderma lucidum inhibits inducible nitric oxide synthase expression in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2006.08.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VASCN.2006.08.002

1 reference

18 September 2017

1 reference